ArticleCureus2026
Utilization of Volume-Targeted Ventilation in Neonatal Intensive Care Units in the United Arab Emirates: A Survey of Practicing Neonatologists.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVolume-targeted ventilation (VTV) is an evidence-based, lung-protective strategy demonstrated to reduce the incidence of bronchopulmonary dysplasia (BPD) and severe neurologic injury in premature infants. While variations in VTV adoption are well-documented in North America and Europe, data characterizing its utilization across the broader Middle East remains limited.
objectiveTo evaluate the utilization rates of VTV, the selection of tidal volume (VT) targets across various clinical scenarios, and the perceived barriers to VTV implementation among practicing neonatologists in the United Arab Emirates (UAE). METHODOLOGY: A cross-sectional survey was distributed to practicing neonatologists across multiple regions in the UAE. The survey assessed clinician and unit characteristics, core ventilation practices, scenario-based VT targeting, and barriers to VTV implementation.
resultsA total of 94 responses were analyzed. VTV was the most commonly reported invasive mode, with 78 (84.8%) of respondents classified as regular VTV users. VTV was predominantly utilized across both the acute and weaning phases of ventilation, with 60 (64.5%) respondents reporting its use. The reported median VT limits ranged from 4.0 to 6.0 mL/kg. Scenario-based responses revealed a median initial VT target of 5.0 mL/kg for a 500-g, 24-week infant with respiratory distress syndrome (RDS), 5.0 mL/kg for a term infant with meconium aspiration syndrome (MAS), and 4.0 mL/kg for an infant with congenital diaphragmatic hernia (CDH). High-frequency oscillatory ventilation (HFOV) was widely used (78, 97.5%); however, the use of volume guarantee (VG) during HFOV remained uncommon (28, 36.4%). Regular VTV use was significantly associated with ≥10 years of experience (
conclusionsThe UAE demonstrates a high rate of VTV adoption, aligning with the most progressive international benchmarks. However, scenario-specific VT targeting reveals a tendency to default to standard volumes regardless of the underlying lung pathophysiology. Continued efforts should focus on optimizing equipment availability and providing targeted education on individualizing VT settings to further elevate neonatal respiratory care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.